Gerber M A, Thung S N
Am J Pathol. 1980 Feb;98(2):395-400.
Characteristic enzyme alterations have been demonstrated during the stages of experimental hepatocarcinogenesis in rats. The activity of gamma-glutamyl transpeptidase (GGTPase) in hyperplastic and neoplastic hepatocytes is usually increased, whereas that of canalicular adenosine triphosphatase (ATPase) and of glucose-6-phosphatase (G6Pase) is more variable. The activities of these marker enzymes were studied by histochemical techniques in 10 human hepatocellular carcinomas (HCCs), 1 liver cell adenoma, and 1 cholangiocarcinoma of liver. In 9 cases, the nontumorous liver was also examined. All HCCs, but not the liver cell adenoma, displayed enzyme patterns that differed from normal. GGTPase activity was markedly increased in 8 HCCs, whereas the activities of G6Pase and ATPase were lost in 6 and 8 HCCs, respectively. These enzyme alterations occurred as 5 of 7 possible combinations, resulting in significant heterogeneity of enzyme phenotypes, similar to that in experimental hepatocarcinogenesis.
在大鼠实验性肝癌发生的各个阶段已证实有特征性的酶改变。增生性和肿瘤性肝细胞中γ-谷氨酰转肽酶(GGTPase)的活性通常会增加,而胆小管三磷酸腺苷酶(ATPase)和葡萄糖-6-磷酸酶(G6Pase)的活性变化则更大。采用组织化学技术对10例人类肝细胞癌(HCC)、1例肝细胞腺瘤和1例肝内胆管癌进行了这些标记酶活性的研究。9例还检查了非肿瘤性肝脏。所有肝细胞癌,但肝细胞腺瘤未出现,表现出与正常情况不同的酶模式。8例肝细胞癌中GGTPase活性显著增加,而6例和8例肝细胞癌中G6Pase和ATPase活性分别丧失。这些酶改变以7种可能组合中的5种形式出现,导致酶表型显著异质性,类似于实验性肝癌发生中的情况。